Micro-RNA Expression Patterns Predict Metastatic Spread in Solid Pseudopapillary Neoplasms of the Pancreas
Authors:
Open Access
- 13 March 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 328
Abstract
Solid pseudopapillary neoplasm (SPN) of pancreas is a rare pancreatic neoplasm with a low metastatic potential. Up to 10% of patients with localized disease at presentation will develop systemic metastases, usually in the peritoneum or the liver. Due to the rarity of SPNs and the overall excellent prognosis, reliable prognostic factors to predict malignant biological behavior remain undetermined. Therefore, we aimed to define clinical, histological, and microRNA patterns that are associated with metastatic disease. We conducted a retrospective single center study on all patients operated for SPN of pancreas between 1995 and 2018. Clinical and pathological data were collected, and expression patterns of 2,578 human microRNAs were analyzed using microRNA array (Affimetrix 4.1) in normal pancreases (NPs), localized tumors (LTs), and metastatic tumors (MTs). The diagnosis of SPN was confirmed in 35 patients who included 28 females and 3 males, with a mean age of 33.8 ± 13.9 years. The only clinical factor associated with metastases was tumor size (mean tumor size 5.20 ± 3.78 in LT vs. 8.13± 1.03 in MT, p < 0.012). Microscopic features of malignancy were not associated with metastases, nor were immunohistochemical stains, including the proliferative index KI67. Higher expressions of miR-184, miR-10a, and miR-887, and lower expressions of miR-375, miR-217, and miR-200c were observed in metastatic tissues on microarray, and validated by real-time polymerase chain reaction. Hierarchal clustering demonstrated that the microRNA expression pattern of MTs was significantly different from that of LTs. The only clinical factor associated with metastases of SPN of pancreas was tumor size. Histological features and immunohistological staining were not predictive of metastases. A panel of six microRNAs was differentially expressed in MTs, and these findings could potentially be used to predict tumor behavior. Validation of these results is needed in larger series.Keywords
This publication has 39 references indexed in Scilit:
- Predicting Recurrence of Pancreatic Solid Pseudopapillary Tumors After Surgical ResectionAnnals of Surgery, 2014
- Solid-pseudopapillary neoplasm (SPN) of the pancreas: case series and literature review on an enigmatic entity.2013
- Solid Pseudopapillary Tumors of the Pancreas. Clinical Features, Surgical Outcomes, and Long-Term Survival in 45 Consecutive Patients from a Single CenterJournal of Gastrointestinal Surgery, 2011
- Differentiation of Benign and Malignant Solid Pseudopapillary Neoplasms of the PancreasJournal of Computer Assisted Tomography, 2009
- Solid pseudopapillary neoplasm of the pancreas: distinct patterns of onset, diagnosis, and prognosis for male versus female patientsSurgery, 2008
- Clinical and biological behavior of pancreatic solid pseudopapillary tumors: Report on 31 consecutive patientsJournal of Surgical Oncology, 2007
- Malignant potential of solid pseudopapillary neoplasm of the pancreasBritish Journal of Surgery, 2006
- Pancreatic Solid‐cystic‐papillary Tumor: Clinicopathologic Features in Eight Patients from Hong Kong and Review of the LiteratureWorld Journal of Surgery, 1999
- [Solid pseudopapillary tumors of the pancreas. Pathology report of 13 cases].1999
- Papillary cystic and solid tumors of the pancreas: A pancreatic embryonic tumor? Studies of three cases and cumulative review of the world's literatureSurgery, 1995